NASDAQ:TBPH

Theravance Biopharma Stock Predictions

Healthcare > Biotechnology

Buy TBPH

*Your capital is at risk

$15.92

+0.340 (+2.18%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

TBPH Prediction Chart

TBPH Predictions History

Latest community submissions for TBPH.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 3, 2019	$23.83 -4.87%	$25.05	X	95.13%	0
NameNotImportant Pro	May 2, 2019	$23.96 -4.73%	$25.15	X	95.27%	0
NameNotImportant Pro	May 1, 2019	$23.57 -0.17%	$23.61	X	99.83%	5

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TBPH with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT THERAVANCE BIOPHARMA

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical tr...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by